Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Synthesis, structural characterization and catalytic application of citrate-stabilized monometallic and bimetallic palladium@copper nanoparticles in microbial anti-activities.

Ullah I, Khan K, Sohail M, Ullah K, Ullah A, Shaheen S.

Int J Nanomedicine. 2017 Dec 12;12:8735-8747. doi: 10.2147/IJN.S145085. eCollection 2017.

2.

Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles.

Guo S, Li H, Ma M, Fu J, Dong Y, Guo P.

Mol Ther Nucleic Acids. 2017 Dec 15;9:399-408. doi: 10.1016/j.omtn.2017.10.010. Epub 2017 Oct 17.

3.

Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.

Binzel DW, Khisamutdinov E, Vieweger M, Ortega J, Li J, Guo P.

RNA. 2016 Nov;22(11):1710-1718. Epub 2016 Sep 26.

4.

Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.

Binzel DW, Shu Y, Li H, Sun M, Zhang Q, Shu D, Guo B, Guo P.

Mol Ther. 2016 Aug;24(7):1267-77. doi: 10.1038/mt.2016.85. Epub 2016 Apr 29.

5.

Caenorhabditis elegans as an alternative in vivo model to determine oral uptake, nanotoxicity, and efficacy of melatonin-loaded lipid-core nanocapsules on paraquat damage.

Charão MF, Souto C, Brucker N, Barth A, Jornada DS, Fagundez D, Ávila DS, Eifler-Lima VL, Guterres SS, Pohlmann AR, Garcia SC.

Int J Nanomedicine. 2015 Aug 10;10:5093-106. doi: 10.2147/IJN.S84909. eCollection 2015.

6.

Nanoscale monitoring of drug actions on cell membrane using atomic force microscopy.

Li M, Liu LQ, Xi N, Wang YC.

Acta Pharmacol Sin. 2015 Jul;36(7):769-82. doi: 10.1038/aps.2015.28. Epub 2015 Jun 1. Review.

7.

Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments.

Binzel DW, Khisamutdinov EF, Guo P.

Biochemistry. 2014 Apr 15;53(14):2221-31. doi: 10.1021/bi4017022. Epub 2014 Apr 2. Erratum in: Biochemistry. 2014 Jun 10;53(22):3709.

8.

Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.

Shu Y, Shu D, Haque F, Guo P.

Nat Protoc. 2013 Sep;8(9):1635-59. doi: 10.1038/nprot.2013.097. Epub 2013 Aug 1.

9.

Targeted delivery of siRNA into breast cancer cells via phage fusion proteins.

Bedi D, Gillespie JW, Petrenko VA Jr, Ebner A, Leitner M, Hinterdorfer P, Petrenko VA.

Mol Pharm. 2013 Feb 4;10(2):551-9. doi: 10.1021/mp3006006. Epub 2013 Jan 8.

10.

Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Guo P, Haque F, Hallahan B, Reif R, Li H.

Nucleic Acid Ther. 2012 Aug;22(4):226-45. doi: 10.1089/nat.2012.0350. Review.

11.

Neurological disorders and therapeutics targeted to surmount the blood-brain barrier.

Kanwar JR, Sriramoju B, Kanwar RK.

Int J Nanomedicine. 2012;7:3259-78. doi: 10.2147/IJN.S30919. Epub 2012 Jul 9. Review.

12.

Nanotechnology in medicine and relevance to dermatology: present concepts.

Basavaraj KH.

Indian J Dermatol. 2012 May;57(3):169-74. doi: 10.4103/0019-5154.96186.

13.

Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.

Shu Y, Cinier M, Shu D, Guo P.

Methods. 2011 Jun;54(2):204-14. doi: 10.1016/j.ymeth.2011.01.008. Epub 2011 Feb 12. Review.

14.

Engineering RNA for targeted siRNA delivery and medical application.

Guo P, Coban O, Snead NM, Trebley J, Hoeprich S, Guo S, Shu Y.

Adv Drug Deliv Rev. 2010 Apr 30;62(6):650-66. doi: 10.1016/j.addr.2010.03.008. Epub 2010 Mar 15. Review.

15.

Salt effects on surface-tethered peptides in solution.

Feng J, Wong KY, Lynch GC, Gao X, Pettitt BM.

J Phys Chem B. 2009 Jul 16;113(28):9472-8. doi: 10.1021/jp902537f.

16.

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE.

J Immunol. 2009 Jul 1;183(1):661-9. doi: 10.4049/jimmunol.0900274. Epub 2009 Jun 17.

17.

Nanoparticles: pharmacological and toxicological significance.

Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW.

Br J Pharmacol. 2007 Mar;150(5):552-8. Epub 2007 Jan 22. Review.

18.

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Dou H, Destache CJ, Morehead JR, Mosley RL, Boska MD, Kingsley J, Gorantla S, Poluektova L, Nelson JA, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE.

Blood. 2006 Oct 15;108(8):2827-35. Epub 2006 Jun 29. Erratum in: Blood. 2007 Mar 1;109(5):1816.

Supplemental Content

Support Center